NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 263 filers reported holding NOVOCURE LTD in Q2 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,432,788 | -36.3% | 34,525 | -7.7% | 0.00% | -33.3% |
| Q1 2023 | $2,250,559 | +77585.8% | 37,422 | -5.3% | 0.00% | -25.0% |
| Q4 2022 | $2,897 | -99.9% | 39,497 | -1.2% | 0.00% | -20.0% |
| Q3 2022 | $3,036,000 | +10.9% | 39,965 | +1.5% | 0.01% | +25.0% |
| Q2 2022 | $2,738,000 | -15.8% | 39,391 | +0.4% | 0.00% | 0.0% |
| Q1 2022 | $3,251,000 | +11.9% | 39,240 | +1.4% | 0.00% | +33.3% |
| Q4 2021 | $2,905,000 | -30.3% | 38,686 | +7.9% | 0.00% | -40.0% |
| Q3 2021 | $4,165,000 | – | 35,849 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |